// App-Quantinova.ai

Filters

Biomarkers

No records found for your search

Conference Name

No records found for your search

Country

























Company

Search valid company name..

Conference Year













Drug











Disease

Medical Centers

Search valid medical center name..

Outcomes





Presenter

Search valid presenter name..

Principal Investigators

Search valid principal investigator name..

Phase










Patient Segments

Search valid patient segment..

Result



Sponsor

Search valid sponsor name..

Study ID

Search your valid Study ID..

Therapeutic Area
























45280 Abstracts

Pulmonary hypertension by right heart catheterization in patients with interstitial lung diease

Nesrin Mogulkoc Bishop - European Respiratory Society (ERS) , 2017

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Interstitial lung disease

N/A

AmbOx trial: does ambulatory oxygen improve quality of life in patients with fibrotic interstitial lung disease?

Dina Visca - European Respiratory Society (ERS) , 2017

Therapeutic Area

Disease

Drug/Treatment

Pulmonary/Respiratory Diseases

Interstitial lung disease

N/A

Analysis of children’s diffuse parenchymal lung disease from the European Management Platform for Childhood Interstitial Lung Diseases: Frequency of disease categories and treatments used

Julia Carlens - European Respiratory Society (ERS) , 2017

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

Prevalence of Latent Infection with Mycobacterium Tuberculosis in Interstitial Lung Diseases Using Interferon Gamma Release Assay

Burcu Uysaler - European Respiratory Society (ERS) , 2017

Therapeutic Area

Disease

Drug/Treatment

Infectious Diseases (ID)

Tuberculosis

Interferon Gamma

Anti-synthetase syndrome associated Interstitial Lung Disease (ASS-ILD): Clinical, serological and radiological heterogeneity

Amila Rathnapala - European Respiratory Society (ERS) , 2017

Therapeutic Area

Disease

Drug/Treatment

Pulmonary/Respiratory Diseases

Interstitial lung disease

N/A

Does enhanced respiratory support affect clinical outcomes in ILD Patients with acute Respiratory failure?

Andrew Achaiah - European Respiratory Society (ERS) , 2017

Therapeutic Area

Disease

Drug/Treatment

Pulmonary/Respiratory Diseases

Acute respiratory failure

N/A

Correlation between lung sounds and HRCT signs of pulmonary fibrosis: a blinded prospective study

Giacomo Sgalla - European Respiratory Society (ERS) , 2017

Therapeutic Area

Disease

Drug/Treatment

Pulmonary/Respiratory Diseases

Interstitial lung disease

N/A

Translation and initial validation of the Saint George´s Respiratory Questionnaire, IPF-specific version

Thomas Skovhus Prior - European Respiratory Society (ERS) , 2017

Therapeutic Area

Disease

Drug/Treatment

Pulmonary/Respiratory Diseases

Idiopathic pulmonary fibrosis

N/A

Anxiety and depression in idiopathic pulmonary fibrosis (IPF): prevalence and clinical correlates

Claire M. Nolan - European Respiratory Society (ERS) , 2017

Therapeutic Area

Disease

Drug/Treatment

Central Nervous System (CNS)

Idiopathic pulmonary fibrosis

N/A

Analysis of baseline characteristics by emphysema extent in patients with idiopathic pulmonary fibrosis (IPF)

Vincent Cottin - European Respiratory Society (ERS) , 2017

Therapeutic Area

Disease

Drug/Treatment

Pulmonary/Respiratory Diseases

Idiopathic pulmonary fibrosis

N/A

Effect of nintedanib on composite physiologic index (CPI) in idiopathic pulmonary fibrosis (IPF)

Athol Wells - European Respiratory Society (ERS) , 2017

Therapeutic Area

Disease

Drug/Treatment

Pulmonary/Respiratory Diseases

Idiopathic pulmonary fibrosis

Nintedanib

Incidence of multiple progression events in patients with idiopathic pulmonary fibrosis (IPF) in the pooled CAPACITY and ASCEND trials

Steven Nathan - European Respiratory Society (ERS) , 2017

Therapeutic Area

Disease

Drug/Treatment

Pulmonary/Respiratory Diseases

Idiopathic pulmonary fibrosis

N/A

Wheezing Characterisation of the Isle of Wight Birth Cohort at 26 Years

Claire Hodgekiss - European Respiratory Society (ERS) , 2017

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

Late Breaking Abstract - Mothers' preconception overweight and offspring asthma

Marianne Lnnebotn - European Respiratory Society (ERS) , 2017

Therapeutic Area

Disease

Drug/Treatment

Autoimmune (AI)

Obesity

N/A

Epigenome-wide association study of asthma and wheeze in childhood and adolescence

Ryan Arathimos - European Respiratory Society (ERS) , 2017

Therapeutic Area

Disease

Drug/Treatment

Autoimmune (AI)

Asthma

IL-4

Respiratory health and dietary patterns in adults from ECRHS III

Liliya Chamitava - European Respiratory Society (ERS) , 2017

Therapeutic Area

Disease

Drug/Treatment

Autoimmune (AI)

Asthma

N/A

Therapeutic ratios predict asthma control in the ASTROLAB cohort

Manon Belhassen - European Respiratory Society (ERS) , 2017

Therapeutic Area

Disease

Drug/Treatment

Autoimmune (AI)

Asthma

N/A

Different relations of exhaled nitric oxide with age and ex-smoking in healthy middle-aged men and women

Andrei Malinovschi - European Respiratory Society (ERS) , 2017

Therapeutic Area

Disease

Drug/Treatment

Autoimmune (AI)

Asthma

Nitric oxide

Epidemiology of pneumothorax: UK national primary care data (1995-2015)

Rob Hallifax - European Respiratory Society (ERS) , 2017

Therapeutic Area

Disease

Drug/Treatment

Genetic Disorder

Primary spontaneous pneumothorax

N/A

Diagnosing primary ciliary dyskinesia (PCD) using electron microscopy and exome sequencing

Suzanne Crowley - European Respiratory Society (ERS) , 2017

Therapeutic Area

Disease

Drug/Treatment

Genetic Disorder

Primary ciliary dyskinesia

N/A

Copyright © 2026. QuantiNova All rights reserved